Smart medical devices

We are developing advanced technological solutions that integrate sensor technology, connectivity and data analysis, improving medical care and optimising outcomes in healthcare systems. 

One of the key innovations is automation in surgical environments and new AI-based tools that open up new perspectives regarding the state of the art of robotic surgery. 3D live bioprinting is also being used in regenerative medicine and advanced therapies, smart patches for transdermal drug delivery, predictive health models or advanced closed-loop neuromodulation systems. Some examples of our developments in healthcare innovation. 

TECNALIA is always looking for double impact, double innovation.  

We are innovating in how our technologies are designed in a world of limited resources and their future capabilities in order to continue to function in the event of risk. 

In this way, we support companies in their differentiation through innovation, improving their competitiveness in a way that enables them to respond to the economic, social and environmental challenges we face. 

Resilient and sustainable applications that enable autonomous or semi-autonomous prevention, diagnosis, monitoring, treatment and rehabilitation through the combined potential of health digitalisation tools, quantum sensing and AI will be the key players over the coming 10 years.

Future medical devices will enable healthcare professionals to make decisions based on augmented reasoning and perception, enabling them to address clinical challenges that are currently beyond the reach of conventional technology.

They will do so through the prism of sustainability: reducing the use of critical materials and the consumption associated with data storage and algorithm processing; facilitating recycling from the design stage; guaranteeing operation in the event of network and/or power outages and enhancing the versatility of modularity.